Peptides & GLP-1 StoreClinically-Backed. Legally Sourced.
The 12 most foundational peptides legally available in 2026 -- sourced from FDA-registered compounding pharmacies and research suppliers. All purchases require a brief telehealth consultation with a licensed provider.
Service Map
Our regulated peptide services are available across North America with country-specific compliance.
United States
Compounded GLP-1s via licensed pharmacies. Research peptides under research-use designation.
Mexico
Broader pharmacy access. Research suppliers and compounded products available with telehealth Rx.
Canada
Health Canada Rx required for GLP-1s. Research-only peptides via research suppliers.
Foundational Peptides & Amino Acids
Hand-picked for clinical efficacy, safety profile, and current legal status. Pricing reflects 15% premium for premium-grade sourcing and provider oversight.
Semaglutide
Clinical-grade GLP-1 weight management
5mg vial (4-week supply)
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A glucagon-like peptide-1 receptor agonist used for weight management and glycemic support. Compounded by FDA-registered pharmacies.
- Chronic weight management in adults with elevated BMI
- Glycemic support in patients with type 2 diabetes (under physician guidance)
- Appetite regulation and improved satiety signaling
Mimics the natural GLP-1 hormone produced in the gut. Slows gastric emptying, reduces appetite by acting on hypothalamic receptors, and improves insulin sensitivity.
Typical titration: 0.25mg weekly subcutaneous for 4 weeks, increase by 0.25mg every 4 weeks up to 2.4mg maintenance dose. Personalized protocol provided during telehealth consultation.
- •Nausea (most common during titration)
- •Constipation or diarrhea
- •Fatigue and headache
- •Injection site reactions
- •Rare: pancreatitis, gallbladder issues
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2
- Pregnancy or breastfeeding
- Severe gastroparesis
Refrigerate 36-46°F. Do not freeze. Protect from light.
Rx-only. Dispensed through our partnered 503A licensed compounding pharmacy after a telehealth consultation with a licensed provider.
Prescription required. Coordinated through our partnered licensed pharmacy network after telehealth review.
Rx via Health Canada. Fulfilled through a licensed pharmacy partner following provider telehealth consult.
GLP-1Retatrutide
GLP-1/GIP/glucagon triple agonist, 10mg lyophilized -- research designation, supplied by US research partner
10mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
Investigational triple-receptor agonist (GIP/GLP-1/glucagon). Phase 2 literature is referenced for educational purposes only. Supplied by a United States-based research partner under research-use designation.
- Reference: published Phase 2 weight-management literature
- Reference: metabolic-syndrome research literature
- Reference: receptor-pharmacology research
Activates three metabolic receptors -- GIP, GLP-1, and glucagon. Mechanism-of-action only; this page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use. Refer to published research literature for protocol context.
- •Adverse events reported in Phase 2 trial literature (nausea, decreased appetite, diarrhea, fatigue) are documented in published reports only
- •Long-term effects in humans remain under active research
- Pregnancy or breastfeeding
- Active malignancy
- Severe renal or hepatic impairment
- Personal MTC or MEN-2 history
Refrigerate 36-46°F. Protect from light. Use within 28 days of reconstitution.
Investigational compound. Not yet FDA approved. Made available exclusively for qualified laboratory research through our supplier network.
Research-only classification. Laboratory research use only.
Not approved by Health Canada. Research use only via qualified suppliers.
HealingBPC-157
BPC-157, synthetic 15-amino-acid pentadecapeptide, 5mg lyophilized -- research designation, supplied by US research partner
5mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A synthetic 15-amino-acid pentadecapeptide derived from a protective gastric protein. Published research literature is referenced for educational context only. Supplied by a United States-based research partner under research-use designation.
- Reference: published tendon and ligament repair literature
- Reference: gastrointestinal lining research literature
- Reference: musculoskeletal recovery research
- Reference: inflammation modulation research
Studied for angiogenesis (new blood vessel formation) and modulation of growth factors in published research models. Mechanism-of-action only; this page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use.
- •Long-term human safety data limited; this product is not intended for human administration
- Active malignancy (theoretical concern)
- Pregnancy
- Unknown allergies to peptide compounds
Lyophilized: room temperature. Reconstituted: refrigerate, use within 30 days.
Not FDA approved as drug. Sold for research use. Removed from compounding bulk list 2023.
Available via licensed research suppliers.
Health Canada classifies as research chemical.
HealingTB-500 (Thymosin Beta-4)
TB-500 (Thymosin beta-4 fragment), 5mg lyophilized -- research designation, supplied by US research partner
5mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A synthetic fragment of Thymosin Beta-4, a naturally occurring peptide studied for cell migration and tissue remodeling. Supplied by a United States-based research partner under research-use designation.
- Reference: published injury-recovery research literature
- Reference: tendon-healing research literature
- Reference: cardiac tissue research models
- Reference: hair-regrowth research studies
Studied for upregulation of actin -- a protein involved in cell motility -- in research models. Mechanism-of-action only; this page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use.
- •Human safety data limited; this product is not intended for human administration
- Active cancer (cellular proliferation concern)
- Pregnancy
- Active autoimmune disease (theoretical)
Refrigerate after reconstitution. Lyophilized form stable at room temp.
Sold for research; banned in WADA-tested athletic competition.
Research use only.
Research designation only.
PerformanceCJC-1295 / Ipamorelin Blend
CJC-1295 + Ipamorelin blend, 10mg lyophilized -- research designation, supplied by US research partner
10mg blend vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A combination peptide -- CJC-1295 (GHRH analog) plus Ipamorelin (selective GHRP). Supplied by a United States-based research partner under research-use designation.
- Reference: published body-composition research literature
- Reference: sleep-quality research models
- Reference: recovery research literature
- Reference: aging-research literature
CJC-1295 studied for extension of growth-hormone half-life; Ipamorelin studied for selective GH-release pathway in research models. Mechanism-of-action only; this page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use.
- •Human safety data limited; this product is not intended for human administration
- Active cancer or tumor history
- Severe diabetes (insulin resistance concern)
- Pregnancy
- Pituitary dysfunction
Refrigerate after mixing. Use within 30 days.
Compounding pharmacy availability tightened 2024. Research designation.
Research suppliers available.
Research use only.
Sexual HealthPT-141 (Bremelanotide)
Centrally-acting libido enhancer
10mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A melanocortin receptor agonist studied for hypoactive sexual desire disorder. FDA-approved as Vyleesi for women. Used research-grade for broader applications.
- Female sexual desire support (Vyleesi-approved)
- Male erectile function research
- Centrally-mediated libido enhancement
Activates melanocortin-4 receptors in the hypothalamus, triggering downstream pathways involved in sexual arousal -- separate from vascular pathways.
Typical: 1-2mg subcutaneous 45 minutes before activity. Maximum 8 doses per month.
- •Nausea (very common, especially first dose)
- •Facial flushing
- •Headache
- •Transient blood pressure elevation
- •Darkening of skin/freckles with frequent use
- Uncontrolled hypertension
- Cardiovascular disease
- Pregnancy
- Concurrent use of certain stimulants
Refrigerate. Stable 30 days post-reconstitution.
Vyleesi brand FDA-approved Rx. Compounded versions research-only.
Rx in some forms; research suppliers also.
Rx via Health Canada.
MetabolicMOTS-c
MOTS-c, mitochondrial-derived 16-amino-acid peptide, 10mg lyophilized -- research designation, supplied by US research partner
10mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A 16-amino-acid peptide encoded within mitochondrial DNA. Supplied by a United States-based research partner under research-use designation.
- Reference: published metabolic research literature
- Reference: insulin-sensitivity research models
- Reference: exercise-research literature
- Reference: aging-research models
Studied for action on the AMPK pathway and mitochondrial function in research models. Mechanism-of-action only; this page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use.
- •Human safety data limited; this product is not intended for human administration
- Pregnancy
- Active malignancy
- Unmanaged endocrine disorders
Refrigerate after reconstitution. Lyophilized stable at room temp.
Research peptide. No drug approval.
Available via research suppliers.
Research designation.
Anti-AgingGHK-Cu (Copper Peptide)
Skin regeneration and hair growth
50mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A naturally occurring copper-binding tripeptide involved in tissue remodeling, collagen synthesis, and antioxidant defense. Best-studied cosmetic peptide.
- Skin regeneration and anti-aging
- Hair follicle stimulation
- Wound healing acceleration
- Topical and injectable applications
Carries copper into cells where it activates antioxidant enzymes and stimulates collagen, elastin, and glycosaminoglycan production.
Subcutaneous: 1-2mg, 2-3 times weekly. Topical: 0.05-0.2% formulation daily.
- •Very mild side effect profile
- •Skin irritation at injection site
- •Rare allergic reaction
- Wilson's disease (copper sensitivity)
- Active copper toxicity
- Pregnancy (precautionary)
Refrigerate after reconstitution. Avoid metal containers.
Available in cosmetic formulations OTC. Injectable form research-grade.
Widely available cosmetically.
Cosmetic use OTC. Injectable research-only.
Anti-AgingEpitalon (Epithalon)
Epitalon, synthetic tetrapeptide, 50mg lyophilized -- research designation, supplied by US research partner
50mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A synthetic tetrapeptide derived from epithalamin, a naturally occurring pineal gland substance. Supplied by a United States-based research partner under research-use designation.
- Reference: published telomere research literature
- Reference: circadian-rhythm research literature
- Reference: aging-research models
- Reference: antioxidant-pathway research
Studied for telomerase enzyme activity and melatonin pathway interactions in research models. Mechanism-of-action only; this page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use.
- •Human safety data limited; this product is not intended for human administration
- Active cancer (theoretical concern -- telomerase activation)
- Pregnancy
- Pituitary tumors
Refrigerate post-reconstitution. Lyophilized stable at room temp.
Research peptide only.
Available via research suppliers.
Research designation.
SleepDSIP (Delta Sleep-Inducing Peptide)
DSIP (Delta Sleep-Inducing Peptide), 5mg lyophilized -- research designation, supplied by US research partner
5mg vial
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A nonapeptide originally isolated from rabbit brain. Supplied by a United States-based research partner under research-use designation.
- Reference: published sleep-onset research literature
- Reference: delta-wave EEG research models
- Reference: cortisol-regulation research
- Reference: pain-modulation research literature
Mechanism not fully elucidated in published literature. Studied for interaction with sleep-regulating receptors and the HPA axis in research models. This page makes no claim of safety or efficacy in humans.
Research-use only. Not intended for human or veterinary administration. This page does not provide dose, route, or frequency for human use.
- •Human safety data limited; this product is not intended for human administration
- Pregnancy
- Concurrent CNS depressants (caution)
- Untreated sleep apnea
Refrigerate post-mixing. Lyophilized stable.
Research peptide.
Research supplier availability.
Research only.
GLP-1Liraglutide
Daily-dosing GLP-1 weight management
18mg multi-dose pen
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A daily-injection GLP-1 agonist. Predecessor to semaglutide, offering daily dosing flexibility and well-established safety profile.
- Chronic weight management (Saxenda)
- Type 2 diabetes (Victoza)
- Daily-dosing alternative for sensitive patients
Same GLP-1 receptor mechanism as semaglutide -- slows gastric emptying, reduces appetite, improves insulin response. Shorter half-life requires daily dosing.
Weight management titration: 0.6mg daily for 1 week, increase 0.6mg weekly to 3.0mg maintenance.
- •Nausea (very common)
- •Diarrhea or constipation
- •Headache
- •Hypoglycemia (with concurrent insulin)
- •Rare: pancreatitis
- Personal/family MTC history
- MEN-2 syndrome
- Pregnancy
- Severe GI disease
Refrigerate unopened. After first use, room temperature for 30 days.
Rx only. Brand-name (Saxenda/Victoza) and compounded dispensing through our partnered 503A licensed pharmacy after telehealth consultation.
Rx required. Coordinated through our licensed pharmacy partner network.
Rx via Health Canada. Fulfilled through a licensed pharmacy partner.
Amino AcidGlycine (Powder + Capsule)
Simplest amino acid -- sleep, recovery, metabolic support
500g powder OR 100ct 1000mg capsules
Product image is illustrative. Labeling, lot number, and packaging on the item you receive may differ based on the fulfilling partner. See full compliance notice.
A non-essential amino acid the body produces naturally but often in insufficient amounts. Sold as supplement-grade powder or 1000mg capsules. OTC dietary supplement in all jurisdictions.
- Sleep quality and onset support
- Cognitive function and memory
- Collagen synthesis and joint health
- Glutathione production (antioxidant precursor)
- Metabolic and blood sugar support
Acts as an inhibitory neurotransmitter in the central nervous system, lowering core body temperature for improved sleep. Supports protein synthesis, collagen formation, and serves as a precursor to glutathione -- the body's master antioxidant.
Powder: 3g (1 teaspoon) before bed for sleep, or 5-15g daily split into doses for general support. Capsules: 1-3g daily with water. Dissolves easily in beverages -- slightly sweet taste.
- •Generally extremely well-tolerated
- •Mild stomach upset at very high doses (>20g)
- •Rare drowsiness during day if dosed before driving
- •No known long-term safety concerns at supplement doses
- Clozapine medication (may reduce efficacy)
- Severe kidney disease (consult provider)
- Pregnancy (consult provider for high doses)
Cool dry place. Keep sealed away from moisture. Shelf-stable 2+ years.
Dietary supplement -- fully OTC. No prescription, no age restriction. Sold at Amazon, Walmart, vitamin shops.
OTC dietary supplement. Widely available.
OTC supplement. Listed in Natural Health Products Database.
Injection Supplies
Helix-branded sterile single-use syringes and supplies for peptide reconstitution and subcutaneous injection. Sourced from FDA-cleared medical-supply distributors.
Most commonHX-SY-030.3 mL Insulin Syringe (U-100)
31G · 5/16" (8mm) · Pack of 100
Smallest barrel = most accurate at low volumes. Half-unit increments easy to read.
Most commonHX-SY-050.5 mL Insulin Syringe (U-100)
30G · 5/16" (8mm) · Pack of 100
Best all-rounder. Works for 80% of peptide protocols.
HX-SY-101 mL Insulin Syringe (U-100)
29G · 1/2" (12.7mm) · Pack of 100
Holds full 1cc draw. Necessary for larger BAC reconstitution volumes.
HX-SY-MIX3 mL Mixing Syringe
21G · 1" (25mm) · Pack of 100
Transfer BAC water into peptide vial. Larger gauge for fast draw. Never inject with this.
HX-SY-TBTuberculin (TB) Syringe -- 1cc
27G · 5/8" (16mm) · Pack of 100
Longer needle reaches muscle. Most peptide protocols are subcutaneous, not IM.
Most commonHX-BAC-30Bacteriostatic Water -- 30 mL Vial
30 mL
Sterile water with 0.9% benzyl alcohol -- preserves reconstituted vial 28 days at 36-46°F.
HX-ALC-200Sterile Alcohol Prep Pads
Pack of 200
Single-use 70% isopropyl pads. Reduces infection risk. Use a fresh pad every time.
HX-SH-CONSharps Disposal Container -- 1 quart
1 qt
Required for safe needle disposal. Most municipalities accept full containers at drop-off sites.
All needles ship sterile, single-use, FDA-cleared. Use a fresh needle every injection -- never reuse. Dispose in an FDA-cleared sharps container.
Compliance, Labeling & Legal Notice
Helix BioMedical operates under a compliance-first model. We work exclusively with licensed pharmacy partners and vetted United States suppliers, we do not manufacture, compound, or re-label primary drug containers, and we maintain documentation supporting every product we make available. This notice explains in plain language how that works, what you should expect to see on the label of any product you receive, and how a regulator, partner, or member of the public can contact us with questions.
How products reach you. Products available through this page fall into one of two channels. Channel A — Prescription products are compounded and dispensed by a licensed compounding pharmacy partner pursuant to a valid prescription issued by an independently licensed prescriber after individualized evaluation. The dispensing pharmacy is the manufacturer of record and is the entity whose name and license appear on the label of the dispensed container. Channel B — Research-use products are supplied by United States-based research suppliers whose label, lot number, and certificate of analysis remain on the primary container. In Channel B, Helix BioMedical is the brand and customer-experience provider only; we do not manufacture or re-label the vial.
Labeling may vary by lot, partner, and channel
Because Helix BioMedical works with multiple qualified pharmacy partners and research suppliers, the label, packaging, lot number, batch information, manufacturer name, and related details printed on the product you receive may differ from any sample image, stock photograph, or representative depiction shown on this website. Product images on this page are illustrative of the compound and presentation, not of the specific lot or partner that will fulfill any given order. The information that controls is the label and accompanying documentation provided with your shipment. If anything about the labeling of a product you receive is unclear, contact us before use and we will provide the corresponding documentation or route you to the issuing pharmacy or supplier.
Research-use designation, where applicable
Products designated for research use are not intended for human or veterinary consumption, ingestion, or administration, are not offered as dietary supplements, and are not represented as safe or effective for any use in humans. Educational descriptions of mechanisms, historical research uses, or protocols referenced in the scientific literature are provided for informational purposes for qualified researchers and do not constitute medical advice, a diagnosis, a treatment recommendation, or an endorsement of human use. Statements on this page have not been evaluated by the U.S. Food and Drug Administration.
Prescription products, where applicable
Where a product is offered as a prescription medication, it is dispensed only after a valid prescription has been issued by a licensed prescriber on the basis of an individualized patient evaluation through our contracted telehealth network. Helix BioMedical does not itself prescribe or practice medicine. The dispensing pharmacy bears the manufacturing, compounding, and dispensing responsibilities under its state and federal licensure. Patient-specific instructions printed by the dispensing pharmacy control over any general information shown on this page.
Supplier & partner confidentiality
The specific identity of Helix BioMedical's pharmacy partners and research suppliers, and the commercial terms of those relationships, are confidential and proprietary. We do not disclose them publicly. We do, however, maintain documentation of each partner's licensure, compliance posture, and applicable certificates of analysis, and we make that documentation available to regulators and to our partners' regulators on request as described below.
Regulatory status varies by jurisdiction
The legal and regulatory status of the compounds described on this page differs by jurisdiction and changes frequently. Certain compounds are subject to active regulatory restriction, import controls, prescription requirements, or agency enforcement in the United States and elsewhere. It is the purchaser's sole responsibility to determine whether a given product may be lawfully purchased, possessed, and used in their jurisdiction and for their intended purpose. Helix BioMedical does not ship to jurisdictions where doing so would be unlawful and makes no representation that any product is lawful in any particular location.
No medical claims
No product described on this page is intended to diagnose, treat, cure, or prevent any disease. We do not make comparative or efficacy claims relative to any FDA-approved branded medication. Where third-party clinical or research literature is referenced, that literature is the source and not a representation by Helix BioMedical that the same outcome will occur for any particular individual.
Assumption of risk & eligibility
By purchasing, you represent and warrant that you are at least 21 years of age, that you are purchasing for a lawful purpose within your jurisdiction, that with respect to any research-use product you are a qualified researcher or research institution and will not administer the product to any person or animal, and that with respect to any prescription product you will use it only as prescribed by your licensed prescriber and dispensed by the pharmacy of record. You assume all risk arising from your acquisition, handling, and any use of these materials.
Limitation of liability
To the maximum extent permitted by law, Helix BioMedical and its officers, members, affiliates, contractors, and partners shall not be liable for any direct, indirect, incidental, consequential, or punitive damages arising from the purchase, handling, misuse, or any use of any material described on this page. Total liability, if any, shall not exceed the amount paid for the specific product giving rise to the claim. Some jurisdictions do not allow certain limitations; in those jurisdictions liability is limited to the greatest extent permitted.
No solicitation where prohibited
This page is informational and does not constitute an offer or solicitation in any jurisdiction where such an offer or solicitation is unlawful or where Helix BioMedical or its partners are not authorized to make it.
Open-Audit & Inquiry Policy.
Helix BioMedical operates on an open-audit basis. We welcome inquiries from regulators, pharmacy boards, supplier-partner compliance officers, payment processors, banking partners, members of the press, and the general public regarding our sourcing, our labeling discipline, our prescriber-network arrangements, and our compliance posture. We maintain dated certificates of analysis, dated batch references where applicable, dated SOPs, and dated change logs, and we will produce relevant documentation on reasonable request. We respond to good-faith regulatory inquiries within five business days.
Compliance inquiries: [email protected] · (702) 825-0288 · General: [email protected]
Helix BioMedical | Mobile Diagnostic & Therapeutic Services | Las Vegas, Nevada | (702) 825-0288
By using this page and/or purchasing, you acknowledge that you have read, understood, and agreed to this notice in its entirety. This notice may be updated at any time; the version in effect at the time of your transaction governs. Nothing on this page is legal or medical advice. Helix BioMedical does not manufacture, compound, or re-label primary drug containers. Last updated: 2026-05-19.
Peptides & GLP-1 -- Frequently Asked Questions
The 30 most common questions about peptide therapy, GLP-1 medications, dosing, legality, and what to expect from telehealth consultations.
01.What are peptides and how do they work?
02.What is a GLP-1 receptor agonist?
03.How does Helix BioMedical source GLP-1 medications?
04.What is BPC-157 and is it legal?
05.What does "research-only" mean for peptides?
06.Do I need a prescription to buy peptides from Helix?
07.What is the typical dose of semaglutide for weight loss?
08.What are the most common side effects of GLP-1 medications?
09.Can I buy peptides in Canada?
10.Are peptides legal in Mexico?
11.What is retatrutide and is it available?
12.How does BPC-157 help with healing?
13.What is the difference between CJC-1295 and Ipamorelin?
14.What is PT-141 used for?
15.How should peptides be stored?
16.How do I reconstitute lyophilized peptides?
17.What is GHK-Cu and what does it do?
18.Are peptides banned for athletes?
19.What is MOTS-c?
20.How long does it take to see results from peptides?
21.Can I take multiple peptides together?
22.Is epitalon really anti-aging?
23.Are peptides safe long-term?
24.Can I drink alcohol while taking peptides?
25.Will insurance cover compounded semaglutide?
26.What happens when I "Buy Now" on a peptide?
27.How fast does Helix BioMedical ship?
28.What if I have side effects after starting a peptide?
29.How does Helix vet supplier quality?
30.Can I cancel or return a peptide order?
Ready to start a peptide protocol?
Telehealth consultations available 7 days a week. Most calls take under 15 minutes.
Call (702) 825-0288